5
pharmaceuticals for the treatment of inflammatory problems and diseases; pharmaceuticals for the treatment of ocular inflammatory diseases, eye dryness and inflammation, and uveitis; pharmaceuticals for the treatment of one or more than one eye condition, eye disease, eye injury, diseases of the posterior segment including diabetic retinopathy, macular edema, macular degeneration or a combination of one or more than one eye condition, eye disease, eye injury, diseases of the posterior segment including diabetic retinopathy, macular edema and macular degeneration; pharmaceuticals for the treatment of psoriasis and eczema; pharmaceuticals for the treatment of one or more than one skin condition, skin disease, or skin injury or a combination of one or more than one skin condition, skin disease and skin injury; pharmaceuticals for the treatment of Crohn's disease; pharmaceuticals for the treatment of gastrointestinal problems and diseases; pharmaceuticals for the treatment of rhinitis and allergies; pharmaceuticals for the treatment of asthma and pulmonary problems and diseases
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen